<--- Back to Details
First PageDocument Content
T cells / Immunology / Receptors / Immune system / Immunoglobulin superfamily / Programmed cell death protein 1 / PD-L1 / B7 / T cell receptor / L1 / CD8 / Co-receptor
Date: 2015-04-20 22:59:48
T cells
Immunology
Receptors
Immune system
Immunoglobulin superfamily
Programmed cell death protein 1
PD-L1
B7
T cell receptor
L1
CD8
Co-receptor

PACGF

Add to Reading List

Source URL: www.caspmi.cn

Download Document from Source Website

File Size: 366,51 KB

Share Document on Facebook

Similar Documents

Medicine / Immunology / T cells / Immune system / Programmed cell death protein 1 / Regulatory T cell / LAG3 / Immune checkpoint / Cytotoxic T cell / T helper cell / Interferon gamma / Natural killer cell

PEGylated IL-10 (AM0010) for advanced solid tumors - a Phase 1 study Jeffrey R. Infante1, Aung Naing2, Kyriakos P. Papadopoulos3, Karen A. Autio4, Patrick A. Ott5, Deborah J. Wong6, Gerald S. Falchook7, Manish Patel1,8 ,

DocID: 1r5tc - View Document

Clinical medicine / Medicine / Antineoplastic drugs / Breakthrough therapy / Pharmacology / Bristol-Myers Squibb / Monoclonal antibodies / Immune system / Programmed cell death protein 1 / Nivolumab / Pharmac / Pembrolizumab

24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box

DocID: 1qVSm - View Document

Immune system / Programmed cell death protein 1

Matanuska-­‐Susitna  Borough  School  District Midnight  Sun  Family  Learning  Center 2016  -­‐  2017 S M

DocID: 1qPCf - View Document

Clinical medicine / Breakthrough therapy / Medicine / Antineoplastic drugs / Pharmacology / Monoclonal antibodies / Bristol-Myers Squibb / Nivolumab / Melanoma / Programmed cell death protein 1 / Pembrolizumab / Raltegravir

12 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box

DocID: 1qIwe - View Document

Medicine / Immunology / T cells / Immune system / Clinical medicine / Antivirals / Cytokines / Interferon gamma / Programmed cell death protein 1 / Cytotoxic T cell / CD8 / CD4+ T cells and antitumor immunity

Anti-tumor activity of PEGylated human IL-10 (AM0010) in patients with Pancreatic or Colorectal Cancer. Kyriakos P. Papadopoulos1*, Aung Naing2*, Jeffrey R. Infante3*, Deborah J. Wong6, Karen A. Autio4, Patrick A. Ott5,

DocID: 1qBPZ - View Document